Autopsy report · NCT00506519
Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis
Cause of deathNo reason given
Life of this trial
- Ran for about 1 year 8 months before it stopped.
- 25 participants enrolled.
- Results were posted on the registry 12 years 6 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- LEO Pharma
- Sponsor type
- Industry
- Conditions
- Disseminated Intravascular Coagulation
- Interventions
- Antithrombin alfa (INN name); Control (Standard treatment)
- Participants
- 25
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.